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Abstract
Background: Noninvasive ventilation (NIV) is frequently used for the management of acute respiratory failure (ARF)
in very old patients (≥ 80 years), often in the context of a do-not-intubate order (DNI). We aimed to determine its
efficacy and long-term outcome.
Methods: Prospective cohort of all patients admitted to the medical ICU of a tertiary hospital during a 2-year
period and managed using NIV. Characteristics of patients, context of NIV, and treatment intensity were compared
for very old and younger patients. Six-month survival and functional status were assessed in very old patients.
Results: During the study period, 1,019 patients needed ventilatory support and 376 (37%) received NIV. Among
them, 163 (16%) very old patients received ventilatory support with 60% of them managed using NIV compared
with 32% of younger patients (p < 0.0001). Very old patients received NIV more frequently with DNI than in
younger patients (40% vs. 8%). Such cases were associated with high mortality for both very old and younger
patients. Hospital mortality was higher in very old than in younger patients but did not differ when NIV was used
for cardiogenic pulmonary edema or acute-on-chronic respiratory failure (20% vs. 15%) and in postextubation (15%
vs. 17%) out of a context of DNI. Six-month mortality was 51% in very old patients, 67% for DNI patients, and 77%
in case of NIV failure and endotracheal intubation. Of the 30 hospital survivors, 22 lived at home and 13 remained
independent for activities of daily living.
Conclusions: Very old patients managed using NIV have an overall satisfactory 6-month survival and functional
status, except for endotracheal intubation after NIV failure.
Introduction
The use of noninvasive ventilation (NIV) as first-line
supportive therapy for acute respiratory failure (ARF) is
increasing in the ICU. The reduced invasiveness of this
technique in selected populations of critically ill patients
leads to better outcomes than with endotracheal intuba-
tion. NIV reduces the need for intubation and decreases
mortality during acute-on-chronic respiratory failure
(AOC), cardiogenic pulmonary edema (CPE), and de
novo ARF in immunocompromised patients [1-6].
Recently, NIV has been proposed for the prevention of
postextubation ARF for at-risk patients, with promising
results [7,8]. The choice of NIV aims to avoid complica-
tions, particularly in fragile patients [9]. Patients aged 80
years or older, also referred to as “very old patients,” are
potentially “good candidates” for a less invasive
management.
The proportion of elderly persons among hospitalized
patients, including ICU admissions, is rapidly growing in
developed countries. In recent epidemiological studies,
very old patients represent 10-15% of ICU admissions
[10-12]. Also, the incidence of ARF increases exponen-
tially with age [13]. Elderly patients are particularly sus-
ceptible to chronic heart failure and pulmonary diseases,
which are classical causes of respiratory failure needing
ICU admission [14]. The management of critical respira-
tory illness in the elderly is therefore of particular
importance. NIV also is frequently proposed for the
respiratory support of patients with a do-not-intubate
order (DNI), as supported by the results of a recent,
randomized controlled study and surveys [15-18].
Although DNI in itself cannot be considered as an
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any medium, provided the original work is properly cited.indication of NIV, the place of NIV as a ceiling therapy
or a comfort treatment for patients with acute respira-
tory failure near the end of life is debated and a better
delineation of the place for palliative NIV among overall
indications of NIV is needed [19]. In this context, we
sought important to isolate NIV performed in the con-
text of DNI.
Whereas NIV is an attractive technique for the man-
agement of ARF in very old persons, specific data for
this population are limited, especially for long-term
mortality [20-23]. The goal of this prospective cohort
study was to identify the conditions in which NIV is
applied to very old patients in the ICU compared with
younger patients and to assess its influence on long-
term outcome and functional status.
Methods
Setting and population
The study was approved by the Ethics Committee of the
French Society of Intensive Care Medicine (n° 08-260).
According to the French legislation, requirement to
obtain written informed consent was waived. During
ICU stay, patients or their surrogates were informed
about data collection for the research and about their
right to refuse. Information about their right to refuse
also was specified at time of phone interview.
The study was conducted in the 24-bed medical ICU
of the Henri Mondor University Hospital. Although NIV
can be started outside of the ICU, patients needing NIV
for ARF are usually admitted to our ICU. In this closed
unit, NIV is managed by ICU physicians and nurses in
charge of the patient. ICU ventilators with oronasal or
total face masks are used for NIV sessions. Pressure
support mode is applied as the first choice. Arterial
blood gases are usually measured after 1 hour of treat-
ment to assess the response to NIV and to modify the
settings accordingly. Due to the growing use of NIV in
our unit, a specific registry for patients who undergo at
least 2 hours of NIV had been implemented [2,24].
The investigator in charge of registry completion was
not involved directly in patient care. In the registry,
severity at admission and at the start of NIV is assessed
by SAPS II [25] and SOFA [26] scores. Patients are pro-
spectively classified according to the context in which
NIV treatment is administered; cardiogenic pulmonary
edema and/or acute-on-chronic respiratory failure,
including COPD exacerbation (CPE-AOC), de novo
ARF, postextubation NIV, and do-not-intubate or rein-
tubate order (DNI) is considered as a separate group. In
t h ec a s eo fm u l t i p l ei n d i c a t i o n so fN I Vd u r i n gt h eI C U
stay, patients with DNI decisions were classified in the
DNI group regardless of the initial cause of ARF, and
non-DNI patients were classified according to the first
indication. NIV failure was defined as the need for
endotracheal intubation and/or a continuing need for
NIV on day 6 and/or ICU death [27]. We added the
continuing need for NIV to the definition of NIV failure
because, in DNI patients, endotracheal intubation is not
applicable. Vital status was recorded at ICU and hospital
discharge.
Additional information on comorbidities and long-
term outcomes was specifically recorded for very old
patients included in the ICU registry from January 1,
2007 to December 31, 2008. Comorbidities were
assessed using the Charlson index [28]. End-stage
chronic respiratory failure definition was based on the
National Hospice Organization guidelines and included
at least two criteria among: O2 or NIV home treatment,
previous ICU admission for ARF within the past year,
FEV1 < 30% of predicted value, or cor pulmonale [29].
For each hospital survivor, vital status and living condi-
tions were assessed by either one ICU nurse or one ICU
physician (AF) through telephone interviews. The first
phone contact was made with the patient’s general prac-
titioner. If this was not possible, the patient’s relatives
or the patients themselves were contacted. For each
patient, phone contact was performed at least 6 months
after ICU admission. A 10-minute interview was devel-
oped using a specific chart that included standardized
questions. The patient’s vital status or date of death, liv-
ing location, and need for home respiratory treatments
(i.e., oxygen and NIV) were recorded. Independence in
activities of daily living (ADL) [30] was assessed in sur-
vivors at the time of phone interview and was used to
retrospectively determine their pre-ICU status. The vali-
dated ADL system assesses the ability of patients for
bathing, dressing, toileting, transfer, continence, and
feeding. For each function, patient dependence was
described as no help, partial assistance, and complete
assistance.
Statistical analysis
Categorical variables were expressed as percentages and
continuous variables as the median and interquartile
range (25
th-75
th IQR). Categorical variables were com-
pared between very old patients and younger patients,
younger than aged 80 years, using the chi-square or
Fisher’s exact test, and continuous variables using the
nonparametric Mann-Whitney test as appropriate. P
value ≤ 0.05 in a two-tailed test was considered statisti-
cally significant. Statistical tests were performed using
Intercooled STATA 8.2 software (StatCorp, Texas,
USA).
Results
Characteristics of very old patients
During the 2-year study period, 1,696 patients were
admitted to the ICU: 1,019 of these patients (60%)
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NIV during their ICU stay (see flow chart in Figure 1).
The proportion of patients needing ventilatory support
was similar in very old (163/253, 64%) and in younger
patients (856/1,443, 59%; p = 0.12). NIV as first-line
therapy was more frequent in very old patients (85/163,
52%) compared with younger patients (194/856, 23%; p
< 0.0001); 13 additional very old patients received NIV
after extubation compared with 84 younger patients.
The characteristics of the 98 very old and the 278
younger patients receiving NIV as first-line ventilatory
support or after extubation during the same period are
indicated in Table 1. The majority of very old patients
(88%) were living at home before hospital admission;
14% had home respiratory support before admission and
18% had been previously admitted to the ICU for ARF.
The most frequent circumstance for NIV use in very old
patients (40%) was a DNI decision compared with only
8% in younger patients. In DNI patients, the cause of
ARF was CPE or COPD exacerbation in 30/39 (77%) of
the very old patients compared with 10/22 (45%) of the
younger patients (p = 0.013). Very old patients had a
significantly higher PaCO2 at the start of NIV and
received NIV for a longer duration than younger
patients.
Survival and functional status of very old patients
The median follow-up was 316 (range, 204-391) days
after ICU admission. ICU and hospital mortality were
28% and 40% respectively (Figure 2). Of the 59 very old
patients discharged alive from hospital, 22 (37%) were
discharged at home and 37 (63%) into a nursing home.
Twenty-nine of the 59 hospital survivors died after hos-
pital discharge with a median time of 231 (range, 136-
474) days. Vital status assessment was not possible in
four patients after hospital discharge; for these patients,
their general practitioners thought that they were possi-
bly dead but had no definitive information, and they
were recorded as dead at 3 months. The overall 3-
month and 6-month mortality rates were 49% and 51%,
respectively (Figure 2).
Thirty very old patients (31%) were alive when con-
tacted for phone interview (Table 2). Twenty-two (73%)
were living at home compared with 27 (90%) before
ICU admission (p = 0.18). An ADL score could be
recorded for all 30 survivors at phone interview (Table
2). Thirteen (43%) returned to total independence in
daily activities compared with 18 (60%) before ICU
admission (p = 0.2). Only five patients were completely
unable to care for themselves. The detail for each activ-
ity is indicated in Table 3. At phone interview, 12 survi-
vors (40%) were under home oxygen (n = 8) or NIV (n
= 4) compared with only two patients needing oxygen
before ICU admission (Table 2). Of note, 8/10 patients
on home O2 therapy and all 4 patients on home NIV
before ICU admission were dead when contacted for
phone interview [12/14 (86%) mortality for those on
home respiratory support].
Comparison of hospital outcome between very old and
younger patients
Compared with the 278 younger patients who received
NIV, very old patients had significantly higher ICU and
hospital mortality (28% vs. 17%, p = 0.03, and 40% vs.
25%, p < 0.01). Hospital mortality was similar in the two
groups when NIV was applied for CPE-AOC respiratory
failure and during the postextubation period, both out
of the context of a DNI order (Figure 3). Hospital mor-
tality was particularly high in the DNI group, both in
very old (56%) and in younger patients (72%; Figure 3).
Among the 39 very old patients with DNI, 10% only
were alive when contacted for phone interview (Figure
4). Very old DNI patients were older, had significantly
more comorbidities, and had more severe hypercapnia
than very old patients with full life support (Table 4).
The Kaplan-Meier survival curves according to DNI sta-
tus are shown in Figure 5.
The incidence of NIV failure was similar between very
old and younger patients (42% vs. 40%, respectively).
The in-hospital mortality of very old patients intubated
because of NIV failure was significantly higher than for
younger patients (10/13, 77% vs. 38/82, 46%, p =0 . 0 1 ;
Figure 4). Among the 13 very old patients requiring
intubation, 8 received NIV for de novo ARF. Intubated
very old patients were significantly more hypoxemic
than nonintubated very old patients (P/F ratio of 110
(100-150) vs. 200 (150-300) mmHg, p < 0.001).
Discussion
This cohort is the largest to date concerning NIV
applied to very old patients in the ICU for ARF and
shows several specific features in comparison to younger
patients. Sixty percent of very old patients needing
Figure 1 Flow chart of the cohort study.
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with only 32% of younger patients, and very old patients
represented 26% of all patients managed with NIV in
our ICU. NIV was applied in 40% of the very old
patients with a DNI order. This large number of very
old patients who received NIV observed in our ICU
warranted the development of a specific long-term fol-
low-up study. The 6-month survival rate of very old
patients was 51% with satisfactory living conditions. The
number of survivors needing chronic respiratory support
was, however, more frequent after than before ICU
admission. Hospital survival of very old patients was
similar to younger patients when NIV was applied for
the recommended indications, i.e., CPE-AOC respiratory
failure and the prevention of postextubation ARF out of
a DNI context. NIV in a context of DNI was associated
Table 1 Characteristics of all patients managed with NIV according to age
Patients ≥ 80 y (n = 98) Patients < 80 y (n = 278) p value
Characteristics at ICU admission
Age, yr 84 (80-86) 67 (54-74) < 0.001
[min-max] [80-94] [17-79]
Gender, M/F, n 45/53 185/93 < 0.001
Home respiratory support, n (%) 14 (14) 28 (10) 0.4
Nasal O2 10 17
NIV 4 11
History of ICU admission for ARF, n (%) 18 (18) 49 (18) 0.87
Immunocompromised, n (%)
a 9 (9) 54 (19) 0.02
Location before ICU admission, n (%) 0.15
Emergency room 59 (60) 140 (50)
Medical ward 28 (29) 110 (40)
Surgical ward 11 (11) 28 (10)
NIV start before ICU admission, n (%) 15 (15) 28 (10) 0.16
SAPS II at admission, points 43 (36-52) 39 (31-49) < 0.01
Non-age-related SAPS II, points
b 25 (18-34) 27 (20-38) 0.21
Characteristics at NIV start
Patients with extra respiratory organ failure, n (%)
c 65 (66) 189 (68) 0.76
NIV context, n (%) < 0.001
CPE-AOC respiratory failure 30 (31) 93 (34)
de novo ARF 16 (16) 79 (28)
Postextubation 13 (13) 84 (30)
Do-not-intubate order 39 (40) 22 (8)
ABG before NIV start
pH 7.35 (7.27-7.42) 7.38 (7.30-7.44) 0.05
PaCO2, mmHg 57 (40-71) 47 (37-60) < 0.01
PaO2/FiO2, mmHg 189 (145-235) 190 (120-240) 0.69
NIV management
NIV duration within the first 24 hours, h 6 (4-10) 4 (3-8) < 0.001
Period of NIV delivery during ICU stay, d 3 (1-5) 2 (1-3) < 0.001
Discharged from ICU with NIV, n (%)
d 9/94 (10) 11/267 (4) 0.05
ABG, arterial blood gases; ARF, acute respiratory failure; CPE-AOC, cardiogenic pulmonary edema and acute-on-chronic respiratory failure; ICU, intensive care unit;
NIV, noninvasive ventilation.
aAIDS, neutropenia < 500/mm
3, immune-suppressive drugs, chemotherapy, long-term, or recent high dose of steroids.
bSimplified
Acute Physiology Score (SAPS II) minus points for age.
cAt least one point in the nonrespiratory SOFA score.
dIn patients without NIV home treatment before ICU
admission.
Figure 2 Outcome in very old patients managed with NIV.
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patients.
The admission of very old patients to the ICU raises
the question of the benefits and risks of invasive suppor-
tive care. In adults requiring mechanical ventilation, the
likelihood of death significantly increased with age [31].
In patients aged 70 years or older, complications during
the course of mechanical ventilation increased the risk
of hospital mortality [32]. This suggests that avoiding
invasive procedures might be particularly crucial in the
elderly, even if the impact of the intensity of care on the
survival of elderly patients is still under debate [33]. The
greater use of NIV in very old patients than in younger
found in our study could be due to physicians choosing
a less invasive technique. Also, neurologic disease is less
frequently the primary reason for mechanical ventilation
in elderly patients and the need for ventilatory support
results more frequently from respiratory distress, which
represents the most frequent reason for ICU referral in
very old patients [32,34].
Previous clinical trials on NIV have included some
very old patients, but the median age was usually
approximately 75 when studying NIV for hypercapnic
ARF, and much younger in case of hypoxemic nonhy-
percapnic ARF [1,2,5,35]. One previous study focused
on 106 very old patients who needed mechanical venti-
lation. The ICU mortality of NIV patients was of 21%,
quite similar to that in our cohort (28%), and with a 2-
year mortality of 88% [21]. Recently, Nava and cowor-
kers reported the result of a RCT on the efficacy of NIV
in patients older than 75 admitted for hypercapnic ARF
[ 1 6 ] .I nt h i ss t u d y ,2 2o f4 1p a t i e n t sw i t hD N Io r d e r s
Table 2 Living conditions of the 30 survivors at phone interview (> 6 months)
Before ICU (n = 30) After ICU (n = 30) p value
Living 0.2
At home, n (%) 27 (90) 22 (73)
Home care, n (%) 3 (10) 8 (17)
Global functional status, n (%) 0.2
Full function (ADL 6) 18 (60) 13 (43)
Moderate impairment (ADL 4-5) 8 (27) 9 (30)
Severe impairment (ADL < 2) 2 (7) 5 (17)
Chronic respiratory support, n (%) < 0.01
No 28 (93) 18 (60)
NIV dependency 0 8 (27)
O2 dependency 2 (7) 4 (13)
ADL, activities of daily living; ICU, intensive care unit; NIV, noninvasive ventilation.
Table 3 Comparison of functional autonomy before and
after ICU admission in the 30 survivors at phone
interview according to the activities of the Katz’s
Activities of Daily Living (ADL) [30]
Before ICU After ICU p value
Bathing, n (%) 0.052
Independent 21 (70) 14 (47)
Partly dependent 8 (27) 9 (30)
Dependent 1 (3) 7 (23)
Dressing, n (%) 0.064
Independent 23 (77) 17 (57)
Partly dependent 6 (20) 6 (20)
Dependent 1 (3) 7 (23)
Toileting, n (%) 0.516
Independent 26 (87) 22 (73)
Partly dependent 2 (7) 3 (10)
Dependent 2 (7) 5 (17)
Transfer, n (%) 0.148
Independent 25 (83) 18 (60)
Partly dependent 3 (10) 7 (23)
Dependent 2 (7) 5 (17)
Continence, n (%) 0.657
Independent 22 (73) 20 (67)
Partly dependent 2 (7) 1 (3)
Dependent 6 (20) 9 (30)
Feeding, n (%) 0.299
Independent 27 (90) 22 (73)
Partly dependent 2 (7) 4 (13)
Dependent 1 (3) 4 (13)
ICU, intensive care unit.
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Figure 3 Hospital mortality according to age and the context
of NIV. DNIO, Do-not-intubate order; CPE-AOC, cardiogenic
pulmonary edema and acute-on-chronic respiratory failure. *p < 0.05
vs. younger patients.
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NIV as a rescue therapy. The mortality rate in this sub-
group was comparable with the overall NIV group. The
6-month mortality of patients who received NIV was
98patients> 80yearsmanagedwithNIV
13Needfor
endotrachealintubation
Hospitalmortality
7/46(15%)
46Noneed for
endotrachealintubation
39with DoNotIntubateOrder
Hospitalmortality
10/13(77%)
Hospitalmortality
22/39(56%)
59withoutDotNotIntubateOrder
6monthmortality
14/46(30%)
6monthmortality
10/13(77%)
6monthmortality
26/39(67%)
Mortalityat phoneinterview
22/46(48%)
Mortalityat phoneinterview
11/13(85%)
Mortalityat phoneinterview
35/39(90%)
Figure 4 Outcome in very old patients according to the
context and success of NIV.
Table 4 Characteristics of very old patients according to do-not-intubate (DNI) status
Very old patients without DNI order
(n = 59)
Very old patients With DNI order
(n = 39)
p
value
Decision of limitation NA
Do not intubate 0 33
Do not reintubate after extubation failure 0 6
Age (yr) 84 (81-85) 86 (83-89) <0.01
Sex Male, n (%) 27 (46) 18 (46) 0.97
Patients living at home before hospital admission, n
(%)
54 (92) 32 (82) 0.16
Charlson comorbidity index, n (%) 0.01
No or low comorbidities (0-1 point) 28 (47) 8 (21)
High comorbidities (> 1 points) 31 (53) 31 (79)
Type of comorbidities
Dementia 1 (2) 6 (15) 0.02
Full dependency for ADL 0 11 (28) <0.001
End-stage respiratory failure 4 (7) 16 (41) <0.001
with home respiratory support 4 10 0.016
Active cancer 7 (12) 4 (10) 0.99
Chronic heart failure 24 (41) 17 (44) 0.77
Peripheral obstructive arterial disease 5 (8) 6 (15) 0.34
SAPS II, points 43 (36-52) 43 (36-50) 0.75
Patients with extra-respiratory OF
a, n (%) 38 (64) 27 (69) 0.67
ABG before NIV start
pH 7.36 (7.27-7.43) 7.32 (7.22-7.4) 0.18
PaCO2 (mmHg) 46 (38-64) 67 (53-80) <0.01
PaO2/FiO2 ratio (mmHg) 180 (120-268) 195 (168-216) 0.59
NIV delivery
Within first 24 hours (h) 6 (4-8) 9 (6-15) <0.001
During ICU stay (d) 2 (1-3) 4 (3-6) <0.001
Continuing need for NIV on day 6, n (%) 3 (5) 12 (33) 0.011
ICU length of stay (d) 8 (5-13) 8 (5-14) 0.87
Among survivors 8 (5-13) 7 (5-14) 0.48
Hospital length of stay (d) 25 (13-40) 20 (8-37) 0.21
Among survivors 27 (17-40) 29 (17-45) 0.25
ADL, activities of daily living; ABG, arterial blood gases.
aOrgan failure (OF) is defined by at least one point in the nonrespiratory SOFA score.
Days after ICU admission
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Figure 5 Kaplan-Meier survival curves of very old patients after
ICU admission. DNI, do-not-intubate.
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RCT were limited to hypercapnic ARF and were slightly
younger and had fewer comorbidities.
Hospital mortality of general populations of ICU very
old patients varies from 24% to 50%, suggesting differ-
ences in the triage for ICU admission [10,12,36]. In 228
very old patients admitted in one ICU in Paris, 3-month
mortality rate was approximately 50% [37]. In a cohort
of 233 patients with similar age and disease severity,
Boumendil et al. showed a 2-month mortality of 41%
[38]. Whereas all patients needed respiratory support in
our cohort, we found a comparable 3-month mortality
rate (49%). We observed that deaths occurred predomi-
nantly within the first 3 months after hospital discharge,
which is consistent with previous reports [37].
The majority of survivors at phone interview were liv-
ing at home with little or no limitation of daily activities
(Table 2), which is in accordance to previous studies
showing little change in functional status after ICU dis-
charge [36,38,39]. The evolution of functional autonomy
varied according to the activity with a trend toward
more dependent patients after ICU stay for bathing,
dressing, and transfer. Pre-ICU status was, however, ret-
rospectively evaluated at phone interview with a poten-
tial bias in case of functional status underestimation.
Whatever the pre-ICU status, only 5 of the 30 survivors
had severe functional impairment. The higher number
of very old patients discharged from the ICU with the
need for NIV and the higher number of survivors need-
i n gc h r o n i cr e s p i r a t o r yc a r ea f t e rt h ee p i s o d eo fA R F
support the hypothesis that age-associated lung patho-
physiological changes predispose elderly patients to the
need for chronic respiratory support when recovering
from ARF [14].
Survival of very old patients depended heavily on the
context in which NIV was applied. The strong impact of
NIV in a context of DNI and de novo ARF on 6-month
mortality precluded any identification of other risk fac-
tors. Development of multivariate analysis in subgroup
of patients based on NIV context was not possible
because of the limited sample size of our population. In
patients with full life support, the use of NIV to reverse
de novo ARF was associated with a poor outcome. The
rate of NIV failure was the highest in this context and
hospital mortality was higher than in younger patients.
Some studies have suggested a potential increase in
mortality associated with NIV failure, in the context of
de novo ARF [40]. Our results suggest that patients who
can benefit from NIV for de novo ARF need to be more
clearly defined, especially in the very old age group. In
addition, in patients with severe chronic respiratory dis-
ability, as indicated by previous home respiratory sup-
port, long-term mortality was extremely high.
NIV is frequently proposed for very old patients with
a DNI decision [23,41]. The outcome of NIV in this
context has received little attention and remains con-
troversial [17,42,43]. Hospital mortality was higher in
very old DNI patients than in very old patients with
full care intensity (56% vs. 27%), but this difference
was larger in younger patients (72% in case of DNI vs.
21%). Two previous studies in critically ill DNI patients
managed with NIV reported hospital mortality of 57%
and 65% [15,18]. Schettino et al. observed that DNI
survivors were older than DNI nonsurvivors [18]. This
difference suggests different reasons for DNI decisions
in elderly and younger patients. Whereas hospital mor-
tality appears acceptable in very old DNI patients, only
four patients remained alive at phone interview. One
previous study of 34 DNI patients of various ages in
whom NIV was applied in the ICU found a 6-month
mortality rate of 85% [41]. The survival of DNI
patients might depend on the cause of ARF, with a
better reported survival at hospital discharge in the
case of NIV for CPE and COPD exacerbations [15,18].
In our cohort, 30/39 DNI very old patients received
NIV to reverse CPE or COPD exacerbation; 14 were
discharged alive from the hospital, but only 2 had sur-
vived at 6 months. For DNI patients, physicians can
apply NIV with the goal of reversing ARF or for the
c o m f o r to fp a t i e n t sa tt h ee n do fl i f e .T h e s et w o
approaches will be associated with different survival
rates. An overlap also can exist between these two
approaches [43]. A limitation of the study, due to its
small sample size, is that we did not separate NIV as a
ceiling therapy and NIV indicated for comfort. Very
old patients with ARF are frequently unable to discuss
and make decisions about their treatment. The DNI
decision was based on advance directives in only one
patient. Treatment limitations are discussed with
family, general practitioners, and are based on deci-
sions of medical and nursing staff. With regard to pre-
ICU cognitive, functional, and respiratory status, lim-
itations of endotracheal intubation seemed justified
(Table 4). Interestingly, the outcome of very old
patients intubated because of NIV failure was no better
than that in patients not intubated due to endotracheal
intubation limitation. Endotracheal intubation after
NIV failure in this population of patients seems of
questionable benefit, and further studies should focus
on the long-term outcome of this subgroup.
Our study is monocentric and only observational. The
frequency and outcome of NIV depend on the expertise
of medical and nursing staff in managing this technique.
Our study illustrates the NIV practice in a specific ICU,
and results cannot be applied for such very old patients
managed on the ward.
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This cohort study outlines our experience of NIV as a
frequently used ventilatory support in very old patients
admitted to the ICU. Importantly, very old patients have
similar hospital survival rates compared to younger
patients when NIV is applied in validated indications
(CPE-AOC respiratory failure and prevention of ARF
during the postextubation period), with an acceptable
long-term outcome. The use of NIV in a palliative con-
text needs to be further addressed regarding its effects
on comfort and outcome, and the outcome after endo-
tracheal intubation in case of NIV failure is particularly
poor in this population of patients.
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